Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | TNKS | O95271 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19797380 | 0.87 | LMNA (0.32) | NPSR1 | |
| SCHEMBL19797369 | 0.87 | NPSR1 (0.34) | NPSR1TNKS | |
| SCHEMBL19797366 | 0.83 | PGR (0.32) | — | |
| SCHEMBL19797376 | 0.82 | NPSR1 (0.31) | NPSR1 | |
| SCHEMBL13832997 | 0.82 | NPSR1 (0.32) | NPSR1 | |
| SCHEMBL15394776 | 0.81 | TNKS (0.33) | TNKS | |
| SCHEMBL19797353 | 0.80 | LMNA (0.34) | NPSR1 | |
| SCHEMBL19797350 | 0.80 | LMNA (0.34) | NPSR1 | |
| SCHEMBL19797378 | 0.80 | NPSR1 (0.32) | NPSR1 | |
| SCHEMBL19797358 | 0.79 | LMNA (0.32) | NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10388889-B2 | Substituted phosphines as components of organic light-emitting devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-08-20 | — | — | US | disclosed |
| US-20180026206-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-01-25 | — | — | US | disclosed |
| US-20180026206-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180026206-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CYP1A1, CYP1B1 | NPSR1 4005/4885TNKS 1805/4885 |
| US-10388889-B2 | Substituted phosphines as components of organic light-emitting devices | CRY1, CRY2, PER2 | NPSR1 2792/4885TNKS 1130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.